EAU 2025 | Optimizing Prostate Biopsy Approaches: Prof. Kan Gong’s Team’s Peri-lesion Biopsy RCT Study Awarded at EAU

EAU 2025 | Optimizing Prostate Biopsy Approaches: Prof. Kan Gong’s Team’s Peri-lesion Biopsy RCT Study Awarded at EAU

2025.04.10
At the 40th Annual European Association of Urology (EAU) Congress, precision biopsy strategies and technological innovation were core topics in the prostate cancer field. With a focus on addressing the limitations of traditional systematic biopsies and MRI-targeted biopsies, multiple studies concentrated on optimizing biopsy approaches to balance diagnostic efficacy and safety. "UroStream" invited Professors Kan Gong and Yi Liu from Peking University First Hospital, along with Dr. Ruiyi Deng, to discuss the latest advancements in prostate cancer biopsy at the EAU conference, their team’s peri-lesion biopsy RCT study findings, and cutting-edge precision biopsy approaches.
Professor Aiwen Wu：Should a “Watch and Wait” Approach Be Considered Before Treating Low Rectal Cancer?    | Annual Meeting of the Chinese Medical Doctor Association Colorectal Oncology Committee

Professor Aiwen Wu：Should a “Watch and Wait” Approach Be Considered Before Treating Low Rectal Cancer?    | Annual Meeting of the Chinese Medical Doctor Association Colorectal Oncology Committee

2025.04.09
In the treatment of low rectal cancer, the “watch and wait” strategy has sparked a compelling debate between organ preservation and radical resection. With the advancement of neoadjuvant therapies, some patients achieve clinical complete response (cCR) following chemoradiotherapy, opening the door to non-operative management and the possibility of avoiding a permanent stoma. However, concerns over local regrowth, subjective response assessment, and the psychological burden on patients continue to challenge the broader application of this approach.
JGCA 2025 | Professor Bo Wei: Two Key Future Directions for Neoadjuvant Therapy in Locally Advanced Gastric Cancer—“Precision and Minimally Invasive Approaches”

JGCA 2025 | Professor Bo Wei: Two Key Future Directions for Neoadjuvant Therapy in Locally Advanced Gastric Cancer—“Precision and Minimally Invasive Approaches”

2025.04.09
From March 12 to 14, 2025, the 97th Annual Meeting of the Japanese Gastric Cancer Association (JGCA 2025) was held at the Nagoya Congress Center, bringing together leading experts from Japan and across the globe to exchange insights on the latest advancements in gastric cancer prevention and treatment. The event also spotlighted the application and future potential of digital innovations in the field.
Professor Chaoxu Zheng: Non-Invasive, Painless Surgery That Preserves Dignity—The Ultimate Goal in Colorectal Cancer Surgery   | Annual Meeting of the Chinese Medical Doctor Association Colorectal Oncology Committee

Professor Chaoxu Zheng: Non-Invasive, Painless Surgery That Preserves Dignity—The Ultimate Goal in Colorectal Cancer Surgery   | Annual Meeting of the Chinese Medical Doctor Association Colorectal Oncology Committee

2025.04.09
From February 28 to March 1, 2025, the 9th Annual Meeting of the Chinese Medical Doctor Association Colorectal Oncology Committee was held in Beijing. This year’s meeting focused on the standardization, precision, and personalization of colorectal cancer diagnosis and treatment, drawing top experts from China and around the world to explore the latest advances in the field.